Electrophysiology devices are used in the diagnosis and treatment of those diseases that occur due to abnormal electrical properties of biological cells and tissues. Electrophysiology devices have wide application in the management of cardiac arrhythmias. The market is expected to record growth mainly due to globally rising geriatric population leading to increasing incidence of arrhythmias and advances in technology that has resulted in minimally invasive procedures and improved features. The global electrophysiology devices market was valued at USD 2,500 million in 2012 and is expected to reach USD 5,496.6 million by 2019, growing at a CAGR of 12.1% from 2013 to 2019. On the other hand, strict regulatory approvals, high cost associated with devices coupled with availability of alternate medications are some of the challenges faced by the electrophysiology devices market.
The market for electrophysiology devices encompasses electrophysiology monitoring as well as treatment devices. These devices enable physicians to understand the nature and origin of abnormal electrical impulses generating in the single ion channel cells to organs such as the heart, brain and eyes, and in turn help in efficient decision making regarding treatment options. Globally, the market for electrophysiology monitoring devices is growing due to rising incidences of cardiovascular diseases that include atrial fibrillation and ventricular tachycardia. Continued product development leads to enhanced digitalization and opening of new EP laboratories worldwide.
The North American region accounted for the largest market share in 2012, followed by Europe. In developed nations such as the United States, Germany, France, Italy, Ireland and Japan, rapidly rising geriatric population coupled with high incidence of rhythmic disorders is one of the highest impact-rendering drivers for this market. Continuously rising economy in Asian-Pacific and Latin American countries leads to increased healthcare expenditure and a large pool of patients suffering from arrhythmias, epilepsy and retinal disorders are major factors anticipated to boost growth of electrophysiology devices in these markets.
The market is dominated by a few major players namely St. Jude Medical, Medtronic, Abbott Laboratories and Boston Scientific. Other players operating in this market are Siemens Healthcare, Philips Healthcare and Johnson & Johnson.
Electrophysiology devices are used in the diagnosis and treatment of those diseases that occur due to abnormal electrical properties of biological cells and tissues. Electrophysiology devices have wide application in the management of cardiac arrhythmias. The study analyzes two major segments of the electrophysiology devices market namely, electrophysiology monitoring devices and treatment devices. The market for electrophysiology monitoring devices comprises for all those devices that are widely used in the diagnosis of atrial fibrillation, atrial flutter, ventricular tachycardia, epilepsy and retinal disorders. Electrophysiology monitoring devices are segmented as electrocardiograph, electroencephalograph, electroretinograph, electromyograph, electrocorticograph, electrooculograph, x-ray systems, imaging and 3D mapping systems, diagnostic electrophysiology catheters and Holter monitoring devices. The market for treatment devices includes pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy devices and catheters. The report also explains various technological advancements taking place in the segment.
The report includes market estimations of the global electrophysiology devices market in terms of value (USD million) for the period 2011 – 2019, considering 2012 as the base year. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global electrophysiology devices market. The report provides market size and forecasts for each segment, sub-segments and geographic region with CAGR in % for the period from 2013 to 2019.
The market is also forecasted in terms of value (USD million) for the period 2013 – 2019 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the electrophysiology devices market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has also been discussed in the study that will help in decision making.
Some of the key market players of the global electrophysiology devices market include Boston Scientific, GE Healthcare, Medtronic, Inc., St. Jude Medical, Philips Healthcare and others. Market players are profiled in this report on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.
The global electrophysiology devices market is segmented into the following categories:
- Electrophysiology Devices Market, by Segments
- Electrophysiology Monitoring Devices Market, by Segments
- Electrocardiograph (ECG)
- Electroencephalograph (EEG)
- Electrocorticograph (ECoG)
- Electromyograph (EMG)
- Electroretinograph (ERG)
- Electrooculograph (EOG)
- Holter Monitoring Devices
- X-Ray Systems
- Imaging and 3D Mapping Systems
- Diagnostic Electrophysiology Catheters
- Electrophysiology Treatment Devices Market, by Segments
- Implantable Cardioverter Defibrillators (ICD’s)
- Cardiac Resynchronization Therapy Devices (CRT)
- Electrophysiology Monitoring Devices Market, by Segments
- Electrophysiology Devices Market, by Geography
- North America
- Rest of the World (RoW)